The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to demonstrate exceptional overall survival (OS) with a 2-year landmark ...

Q1 2025 Management View CEO Bruce Cozadd highlighted strong momentum in Q1 2025, driven by robust growth from key products ...

Ugur Sahin; Chief Executive Officer, Member of the Management Board; Biontech SE Oezlem Tuereci; Chief Medical Office, Member of the Management Board; Biontech SE Welcome to BioNTech's first-quarter ...

Janssen-Cilag International NV, a Johnson & Johnson company, has submitted an application to the European Medicines Agency ...

WESTLAKE VILLAGE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of ...

Results published in the peer-reviewed journal Investigational New DrugsStudy in heavily pre-treated patients with solid tumor indications ...

Medically reviewed by Katlein Franca, MD Sunspots (also called age or liver spots) appear as flat brown spots on the skin.

Understanding the warning signs, risk factors and available treatments is crucial for early detection, effective treatment ...

The co-founder and bassist for the group has released his first memoir, Fahrenheit-182, which details his formative years, ...

The LENOWISCO Health District is asking parents of children diagnosed with cancer in the last 10 years to fill out a survey ...